Soergel David
Insider CIK 1591475 · MDGL Chief Medical Officer · TRVN Sr. VP,Clinical Dev. & CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-06-01 | 2026-06-01 | 1,042 | $495.74 | $516.6K | 10,033 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-18 | 2026-05-18 | 844 | $515.90 | $435.4K | 11,075 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2026-03-04 | 2026-03-06 | 5,467 | — | $0 | 5,467 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2026-03-04 | 2026-03-06 | 4,374 | — | $0 | 11,919 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-05-15 | 2025-05-16 | 12,839 | — | $0 | 12,839 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-05-15 | 2025-05-16 | 7,545 | — | $0 | 7,545 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2017-03-02 | 2017-03-03 | 91,000 | — | $0 | 91,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2017-01-06 | 2017-01-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 105,000 | — | $0 | 105,000 | SEC↗ |
| TRVN TREVENA INC | S Sale | 2015-12-10 | 2015-12-11 | 27,217 | $10.55 | $287.1K | 1,750 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2015-03-17 | 2015-03-19 | 87,500 | — | $0 | 87,500 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-10 | 2014-12-10 | 1,250 | $4.00 | $5.0K | 28,467 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-10 | 2014-12-10 | 1,250 | $4.00 | $5.0K | 28,967 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-09 | 2014-12-10 | 500 | $3.97 | $2.0K | 27,717 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2014-02-20 | 2014-03-11 | 55,000 | — | $0 | 55,000 | SEC↗ |